Figure 3From: Comparison of treatment patterns and economic outcomes in metastatic breast cancer patients initiated on trastuzumab versus lapatinib: a retrospective analysis Comparison of discontinuation rates between patients initiated on trastuzumab and patients initiated on lapatinib. Back to article page